LFM-A13 is a specific Bruton's tyrosine kinase (BTK) inhibitor with IC50 of 2.5 ?M, >100-fold selectivity over other protein kinases including JAK1, JAK2, HCK, EGFR,and IRK.
choosing a selection results in a full page refresh
Product has been added to your wishlist.
You can view your wishlist by creating or login account.
Please create account through ##customer_email## email
